Moody’s affirms Concord Hospital’s ‘A2’ rating

Moody’s Investors Service has affirmed Concord (N.H.) Hospital’s “A2” rating, affecting $80.4 million of rated bonds.

Advertisement

The rating affirmation is supported by CH’s leading market share in a demographically favorable primary service area and Moody’s expectation of improved performance going forward given the June 2014 settlement with the state over Medicaid disproportionate share funding.

The system outlook is stable, reflecting Moody’s belief that CH will continue to produce consistent results and improve balance sheet and debt measures.

More articles on finance:
5 most-read finance stories: Week of Aug. 10-14
IASIS Healthcare suffers $1.7M loss in Q3
Medicare’s voluntary bundled payment program grows by 2,100 participants 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.